ArticleBulletin of experimental biology and medicine2025
Total and Reduced Aminothiols in Blood Plasma as Biochemical Markers of the Effectiveness of Hemodialysis Therapy in Patients with End-Stage Renal Disease.
Article in Bulletin of experimental biology and medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The redox status of aminothiols in the blood plasma of 15 patients with end-stage renal disease before and against the background of hemodialysis therapy was compared with that of relatively healthy volunteers. An increase in the plasma content of total cysteine and homocysteine in patients before dialysis was revealed. An increase in the level of oxidized forms of these compounds was also noted. The hemodialysis procedure was accompanied by a significant shift of the redox status towards an increase in the reduced forms typical of healthy people. Oxidized forms of aminothiols can be used as biomarkers of uremic conditions in patients with end-stage renal disease. At the same time, the predominance of reduced forms of compounds may be an indicator of the effectiveness of renal replacement therapy, including hemodialysis.
Indexed as
Identifiers
39969685What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.